The role of glutamate in the pathophysiology of Parkinson's disease.
Blandini
F
F
Neurological Institute C. Mondino, University of Pavia, Italy.
Greenamyre
J T
JT
Nappi
G
G
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000009:adverse effects / Q000494:pharmacology; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology / Q000627:therapeutic use; D001479:Basal Ganglia / Q000033:anatomy & histology / Q000502:physiology / Q000503:physiopathology; D004195:Disease Models, Animal; D004298:Dopamine / Q000502:physiology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D018698:Glutamic Acid / Q000502:physiology / Q000633:toxicity; D006801:Humans; D015640:Ion Channel Gating / Q000502:physiology; D008928:Mitochondria / Q000187:drug effects / Q000502:physiology; D009434:Neural Pathways / Q000033:anatomy & histology / Q000502:physiology / Q000503:physiopathology; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy / Q000503:physiopathology*; D011323:Primates; D051381:Rats; D018091:Receptors, AMPA / Q000502:physiology; D017470:Receptors, Glutamate / Q000145:classification / Q000502:physiology; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology*
D000978:Antiparkinson Agents; D018691:Excitatory Amino Acid Antagonists; D018696:Neuroprotective Agents; D018091:Receptors, AMPA; D017470:Receptors, Glutamate; D016194:Receptors, N-Methyl-D-Aspartate; D018698:Glutamic Acid; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine